Have a feature idea you'd love to see implemented?
Let us know!
VERA Vera Therapeutics Inc
Price (delayed)
$39.79
Market cap
$2.18B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.21
Enterprise value
$2.21B
Highlights
VERA's equity has soared by 133% year-on-year but it is down by 7% since the previous quarter
VERA's EPS is up by 34% year-on-year but it is down by 8% since the previous quarter
VERA's debt has soared by 76% year-on-year
The quick ratio has contracted by 25% from the previous quarter
Key stats
What are the main financial stats of VERA
Market
Valuations
Earnings
Shares outstanding
54.83M
Market cap
$2.18B
Enterprise value
$2.21B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.64
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$102.03M
EBITDA
-$102.51M
Free cash flow
-$106.88M
Per share
Balance sheet
Liquidity
EPS
-$2.21
Free cash flow per share
-$1.95
Book value per share
$5.99
Revenue per share
$0
TBVPS
$7.26
Total assets
$397.29M
Total liabilities
$69.42M
Debt
$52.83M
Equity
$327.87M
Working capital
$376.33M
Debt to equity
0.16
Current ratio
21.43
Quick ratio
20.87
Net debt/EBITDA
-0.27
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-36.9%
Return on equity
-47.6%
Return on invested capital
-36.8%
Return on capital employed
-26.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VERA stock price
How has the Vera Therapeutics stock price performed over time
Intraday
-0.25%
1 week
-0.25%
1 month
-14.81%
1 year
295.53%
YTD
158.71%
QTD
-9.98%
Financial performance
How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$117.24M
Net income
-$107.85M
Gross margin
N/A
Net margin
N/A
VERA's operating income is down by 15% since the previous quarter and by 4.6% year-on-year
The net income has contracted by 14% from the previous quarter
Growth
What is Vera Therapeutics's growth rate over time
Valuation
What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
6.64
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS is up by 34% year-on-year but it is down by 8% since the previous quarter
VERA's equity has soared by 133% year-on-year but it is down by 7% since the previous quarter
VERA's P/B is 9% more than its last 4 quarters average of 6.1
Efficiency
How efficient is Vera Therapeutics business performance
The ROIC has soared by 62% YoY and by 11% from the previous quarter
VERA's return on equity is up by 47% year-on-year and by 9% since the previous quarter
The ROA has increased by 43% year-on-year and by 6% since the previous quarter
Dividends
What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VERA.
Financial health
How did Vera Therapeutics financials performed over time
VERA's total assets has surged by 104% year-on-year but it is down by 5% since the previous quarter
The total liabilities has increased by 27% year-on-year and by 5% since the previous quarter
VERA's debt is 84% smaller than its equity
VERA's equity has soared by 133% year-on-year but it is down by 7% since the previous quarter
VERA's debt has soared by 76% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.